In this meta‐analysis, we attempted to comprehensively analyze the efficacy and safety of PD‐1/PD‐L1 based immunochemotherapy for advanced ESCC, and to evaluate the effect of PD‐L1 expression level on the treatment outcome. Here, PDCD1 is linked to esophageal squamous cell carcinoma.